US$14.5 million financing of NSG Bio Global Pte. Ltd. co-led by ClavystBio Investments Pte. Ltd.
Allen & Gledhill, as transaction counsel, advised ClavystBio Investments Pte. Ltd. (“ClavystBio”), which co-led the US$14.5 million financing round of NSG Bio Global Pte. Ltd. (“NSG BioLabs”).
ClavystBio is a life sciences investor and venture builder set up by Temasek.
NSG BioLabs is a hub for biotech innovation, supporting developing life sciences companies by fitting-out, operating and managing Singapore's largest and leading level 2 biosafety co-working laboratory and office space.
Advising ClavystBio was Allen & Gledhill Partner Nicholas Soh.
